Submit your Procrit claim details for a free, no obligation case review
Get Started:
A Procrit lawyer can help individuals who have suffered a side effect of Procrit® or a similar drug. Patients with chronic kidney failure, chemotherapy-induced anemia, or HIV are often prescribed Procrit®, Epogen®, or Aranesp® to increase their hemoglobin levels. Each of these drugs is linked to life-threatening side effects that include heart attack, stroke, blood clots, and heart failure. Patients who incur these injuries due to Procrit treatment may be able to obtain reimbursement for medical expenses and other losses.
Why Should I Consult a Procrit Lawyer?
If serious side effects due to Procrit use have affected you or a loved one, a Procrit lawyer can help you recover compensation for your:
Pharmaceutical companies have a duty to produce safe and effective drugs, and they have the obligation to inform consumers and healthcare professionals about the potential risks associated with the drugs they market. When a pharmaceutical company fails to fulfill this duty, it can be held legally responsible for injuries incurred by individuals as a result.
What Can a Procrit Lawyer Do for Me?
Not all attorneys are experienced in litigation targeting pharmaceutical companies. The complex medical details of Procrit claims and similar drug cases are best dealt with by an experienced litigator who can accurately evaluate your case, advise you of your legal rights and options, and plan a course of action with you to obtain the legal outcome you deserve. A Procrit lawyer may be able to help you obtain financial reimbursement by negotiating a settlement with the liable party(s) or by trying your case before a jury.
Injured by Procrit?
If you’ve suffered injury due to Procrit treatment, contact us today to arrange a consultation. We look forward to helping you.
A Food and Drug Administration advisory panel is recommending restrictions on the use of anemia drugs for cancer patients.
The panel recommendation comes in response to growing safety concerns over the risks associated with the anemia drugs Ar...
Anemia drugs known as erythropoiesis-stimulating agents (ESAs) may speed up cancer growth and lead to earlier death in some patients, the Food and Drug Administration announced today citing two new studies.
November Warning
...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice